\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ unremarkable\\.laboratory\\ significant\\ for\\ hct\\ of\\ 21\\.\\ \\ \\ endoscopy\\ revealed\\ a\\ 2\\-3\\ cm\\ ulcerated\\ mass\\ at\\ the\\ gatroesophageal\\ junction\ \(0\)\
\-\ this\\ patient\\ will\\ initially\\ receive\\ adjuvant\\ chemotherapy\\ \\ \\(5\\-\\ fluorouracil\\ \\)\\ and\\ radiotherapy\\.\\ \\ she\\ will\\ then\\ undergo\\ surgical\\ resection\\ of\\ her\\ tumor\\ followed\\ by\\ additional\\ adjuvant\\ chemotherapy\\ and\\ radiotherapy\\ to\\ prevent\\ recurrence\\.\ \(0\)\
\-\ ct\\ of\\ chest\\,\\ abdomen\\,\\ and\\ pelvis\\ with\\ contrast\\-\\ \\ lobular\\ thickening\\ of\\ the\\ lower\\ esophageal\\ wall\\ and\\ luminal\\ wall\\ at\\ the\\ ge\\ junction\\;\\ no\\ adenopathypet\\-\\ no\\ abnormal\\ findingsesophageal\\ us\\-t2\\/t3\ \(0\)\
\-\ adenocarcinoma\\ of\\ the\\ gastroesophageal\\ junction\\,\\ no\\ evidence\\ of\\ barrett\\ esophagus\\ found\\ \\-\\ stage\\:\\ t3n0m0\ \(0\)\
\-\ malignancy\\,\\ leiomyoma\\ or\\ benign\\ tumor\\,\\ irritation\\,\\ inflammation\ \(0\)\
\-\ the\\ patient\\ is\\ a\\ 39\\ year\\ old\\ female\\ with\\ a\\ chief\\ complaint\\ of\\ worsening\\ solid\\ and\\ liquid\\ dysphagia\\ over\\ a\\ \\>6\\ months\\ duration\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ junction\\:\\ 0\\.2648184007698821\ \(0\)\
\-\ adjuvant\\:\\ 0\\.25649660862438944\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.2387389472279269\ \(0\)\
\-\ fluorouracil\\:\\ 0\\.17626030267195983\ \(0\)\
\-\ findingsesophageal\\:\\ 0\\.17626030267195983\ \(0\)\
\-\ t3n0m0\\:\\ 0\\.17626030267195983\ \(0\)\
\-\ gatroesophageal\\:\\ 0\\.16842612905940502\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.1565221242780058\ \(0\)\
\-\ of\\:\\ 0\\.15098227550758722\ \(0\)\
\-\ will\\:\\ 0\\.14187667687768035\ \(0\)\
\-\ barrett\\:\\ 0\\.14009437142666692\ \(0\)\
\-\ ulcerated\\:\\ 0\\.13866249798474364\ \(0\)\
\-\ wall\\:\\ 0\\.1340920367900049\ \(0\)\
\-\ liquid\\:\\ 0\\.13276208186303354\ \(0\)\
\-\ ge\\:\\ 0\\.13177102106555363\ \(0\)\
\-\ irritation\\:\\ 0\\.12992949023910405\ \(0\)\
\-\ luminal\\:\\ 0\\.12745956420635773\ \(0\)\
\-\ gastroesophageal\\:\\ 0\\.11936947361396345\ \(0\)\
\-\ chief\\:\\ 0\\.11653688199003397\ \(0\)\
\-\ receive\\:\\ 0\\.11610267384044398\ \(0\)\
\-\ tumor\\:\\ 0\\.11529933016002919\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.11445730154659753\ \(0\)\
\-\ endoscopy\\:\\ 0\\.11406695595728764\ \(0\)\
\-\ and\\:\\ 0\\.11387453248469702\ \(0\)\
\-\ lobular\\:\\ 0\\.11187728148660345\ \(0\)\
\-\ the\\:\\ 0\\.10996100500542597\ \(0\)\
\-\ no\\:\\ 0\\.10752353126467697\ \(0\)\
\-\ duration\\:\\ 0\\.10623278234473281\ \(0\)\
\-\ hct\\:\\ 0\\.10450870750008967\ \(0\)\
\-\ undergo\\:\\ 0\\.10292594995469036\ \(0\)\
\-\ prevent\\:\\ 0\\.10106469329752743\ \(0\)\
\-\ dysphagia\\:\\ 0\\.0995485079421594\ \(0\)\
\-\ complaint\\:\\ 0\\.09545703201144014\ \(0\)\
\-\ esophageal\\:\\ 0\\.09417321637833745\ \(0\)\
\-\ 39\\:\\ 0\\.09159319631834337\ \(0\)\
\-\ recurrence\\:\\ 0\\.09099864326921316\ \(0\)\
\-\ esophagus\\:\\ 0\\.09076585190494768\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.09008384759081296\ \(0\)\
\-\ inflammation\\:\\ 0\\.08858030992267737\ \(0\)\
\-\ stage\\:\\ 0\\.0877709162077059\ \(0\)\
\-\ initially\\:\\ 0\\.08643126943017777\ \(0\)\
\-\ additional\\:\\ 0\\.08544020863269787\ \(0\)\
\-\ solid\\:\\ 0\\.08449751193933304\ \(0\)\
\-\ worsening\\:\\ 0\\.08416580508852312\ \(0\)\
\-\ at\\:\\ 0\\.08326039374084332\ \(0\)\
\-\ malignancy\\:\\ 0\\.0825120449284692\ \(0\)\
\-\ then\\:\\ 0\\.07802029329753679\ \(0\)\
\-\ pelvis\\:\\ 0\\.07708614402722905\ \(0\)\
\-\ benign\\:\\ 0\\.07571135024131054\ \(0\)\
\-\ thickening\\:\\ 0\\.07498215239986888\ \(0\)\
\-\ followed\\:\\ 0\\.07442791376125107\ \(0\)\
\-\ revealed\\:\\ 0\\.07226841935289764\ \(0\)\
\-\ patient\\:\\ 0\\.07169583974595163\ \(0\)\
\-\ found\\:\\ 0\\.0713151500466805\ \(0\)\
\-\ resection\\:\\ 0\\.07065026037271253\ \(0\)\
\-\ her\\:\\ 0\\.06885706572918804\ \(0\)\
\-\ abdomen\\:\\ 0\\.06725048008609412\ \(0\)\
\-\ abnormal\\:\\ 0\\.06621664431098086\ \(0\)\
\-\ she\\:\\ 0\\.06560930309125568\ \(0\)\
\-\ months\\:\\ 0\\.06415496545716634\ \(0\)\
\-\ significant\\:\\ 0\\.06363662425098678\ \(0\)\
\-\ cm\\:\\ 0\\.06329863109267277\ \(0\)\
\-\ evidence\\:\\ 0\\.06255909484362959\ \(0\)\
\-\ over\\:\\ 0\\.061285263066844266\ \(0\)\
\-\ physical\\:\\ 0\\.0597619587955468\ \(0\)\
\-\ chest\\:\\ 0\\.0581778950672339\ \(0\)\
\-\ lower\\:\\ 0\\.056320791844611515\ \(0\)\
\-\ exam\\:\\ 0\\.055483080565420444\ \(0\)\
\-\ surgical\\:\\ 0\\.053568852245085175\ \(0\)\
\-\ female\\:\\ 0\\.05318458247719639\ \(0\)\
\-\ by\\:\\ 0\\.04680435135465864\ \(0\)\
\-\ with\\:\\ 0\\.043163567823207405\ \(0\)\
\-\ mass\\:\\ 0\\.042099790594565915\ \(0\)\
\-\ ct\\:\\ 0\\.04196048610139854\ \(0\)\
\-\ or\\:\\ 0\\.03834238497808619\ \(0\)\
\-\ this\\:\\ 0\\.0378724010884671\ \(0\)\
\-\ year\\:\\ 0\\.033966579405123584\ \(0\)\
\-\ for\\:\\ 0\\.033405798958639495\ \(0\)\
\-\ old\\:\\ 0\\.03261967405216863\ \(0\)\
\-\ is\\:\\ 0\\.030183558737078883\ \(0\)\
\-\ to\\:\\ 0\\.0275539280376264\ \(0\)\
